Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,135
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,799
Class I recallsReasonable probability of serious health consequences
24,349
Class II recallsTemporary or medically reversible health consequences
2,891
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/gf-blends-recalls-truly-aip-all-purpose-flour-and-bread-mix-and-eat-gangster-flat-bread-pizza-mixPublished September 18, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1

Showing 10,361–10,380 of 18,726 recalls

FDA Recall Terminated Historical recordClass I

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 2 grain (120 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-158-04.

by Westminster Pharmaceuticals LLC

Reason
Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1/4 grain (15 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-159-04.

by Westminster Pharmaceuticals LLC

Reason
Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1/2 grain (30 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-155-04.

by Westminster Pharmaceuticals LLC

Reason
Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1 & 1/2 grain (90 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-157-04.

by Westminster Pharmaceuticals LLC

Reason
Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1 grain (60 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-156-04.

by Westminster Pharmaceuticals LLC

Reason
Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall Completed Historical recordClass II

Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 320 mg, 90 tablets, Rx Only Manufactured for: Camber Pharmaceuticals, Inc. Piscataway NJ 08854 By: Hetero Hetero Labs Limited Unit V, Pollepally Jadcherla Mahaboob Nagar - 509-301 India. NDC 31722-748-90 UPC 331722748902

by Hetero Labs Limited Unit V

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall Completed Historical recordClass II

Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 160 mg, 90 tablets Rx Only Manufactured for: Camber Pharmaceuticals, Inc. Piscataway NJ 08854 By: Hetero Hetero Labs Limited, Unit V, Pollepally Jadcherla Mahabubnagar - 509-301, India. NDC 31722-747-90 UPC 331722747905

by Hetero Labs Limited Unit V

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall Completed Historical recordClass II

Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 80 mg, 90 count bottles, Rx Only Manufactured for: Camber Pharmaceuticals, Inc. Piscataway NJ 08854 By: Hetero Hetero Labs Limited Unit V. Polepally Jadcherla Mahaboob Nagar - 509-301 India. NDC 31722-746-90 UPC 331722746908

by Hetero Labs Limited Unit V

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall Completed Historical recordClass II

Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 40 mg, 30 Tablets Rx Only Manufactured for: Camber Pharmaceuticals, Inc. Piscataway NJ 08854 By: Hetero Hetero Labs Limited Unit V, Polepally Jadcherla Mahaboob Nagar - 509-301, India. NDC 31722-745-30 UPC 331722745307

by Hetero Labs Limited Unit V

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Diltiazem HCl Extended-release Capsules, USP 120 mg, 80 capsules, 8 blister cards of 10 capsules each per carton, Rx Only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV. NDC 51079-947-08

by Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Reason
Failed Impurities/Degradation Specifications; out of specification results for related compound per the manufacturer
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Valsartan and Hydrochlorothiazide Tablets, Valsartan 320 MG and Hydrochlorothiazide 25 MG, 90 tablets per bottle, Rx Only, MFG: Arrow Pharm (Malta) LTD, Birzebbugia, BBG 3000 Malta. NDC: 54569-6488-0

by A-S Medication Solutions LLC.

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Valsartan and Hydrochlorothiazide Tablets, Valsartan 160 MG and Hydrochlorothiazide 12.5 MG, 90 tablets per bottle, Rx Only, MFG: Arrow Pharm (Malta) LTD, Birzebbugia, BBG 3000 Malta. NDC: 54569-6480-0

by A-S Medication Solutions LLC.

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Valsartan Tablets, 80 MG, 30-count bottle (NDC 54569-6582-0, 90-count bottle (NDC 54569-6582-1), Rx Only, MFG: Zhejiang Huahai Pharma, Linhai, Zhejiang 317024 China

by A-S Medication Solutions LLC.

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Valsartan Tablets, 160 MG, 30-count bottle (NDC 54569-6583-0), 90-count bottle (NDC 54569-6583-1), Rx Only, MFG: Zhejiang Huahai Pharma, Linhai, Zhejiang 317024 China

by A-S Medication Solutions LLC.

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

Country Favor Inc.

Product
BEST TASTE BRAND SNACK GINGER SLICED, Net Weight 200g, 7 OZ,…
Reason
Product contains high levels of undeclared sulfites.
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

SALT & STRAW LLC

Product
Chocolate Gooey Brownie Ice Cream, packaged in pint-sized co…
Reason
Chocolate Gooey Brownie Ice Cream is recalled due to possible undeclared peanuts.
Published
August 29, 2018
Distribution
Distributed in CA, OR, and WA. Firm a…

View recall →

FDA Recall United States Terminated Historical recordClass I

Gift Services Inc Warehouse

Product
Sherman Candy Caramels are individually wrapped in plastic a…
Reason
Sherman Candy Caramels product is recalled due to undeclared pecans, walnuts, almonds and/or peanuts.
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Natures Bounty Inc

Product
BLUE GREEN ALGAE: Packaged under the following brands: AMERI…
Reason
High level of microcystin observed in the product.
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99.

by Orexigen Therapeutics, Inc.

Reason
Defective Container: Customer complaints of punctures in the bottle.
Published
August 22, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Atorvastatin Calcium tablets, 40 mg, 500-count bottle, Rx only, Mfd By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 India, NDC 55111-123-05

by Dr. Reddy's Laboratories, Inc.

Reason
Failed Impurities/Degradation Specifications - OOS was observed for ATV Cyclo FP Impurity and Total Degradation Impurities tested at the 18 month stability time point in Atorvastatin Calcium Tablets 40 mg 500 tablets.
Published
August 22, 2018
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.